CAR T-cell therapy is a groundbreaking cancer treatment that reprograms a patient’s own immune cells to recognize and destroy cancer. First approved by the FDA in 2017, it’s already shown success in patients with blood cancers that no longer respond to standard treatments. While the therapy can cause serious side effects, our expert this week –a pioneer of this therapy– discusses the future of using this powerful new weapon against cancer.
Guest Information:
- Dr. Michel Sadelain, genetic engineer and cell therapist, Columbia University, Director, Columbia Initiative in Cell Engineering and Therapy
Leave a Reply